Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.410
-0.060 (-2.43%)
Jan 29, 2026, 10:54 AM EST - Market open
Nkarta Employees
Nkarta had 105 employees as of September 30, 2025. The number of employees decreased by 54 or -33.96% compared to the same quarter last year.
Employees
105
Change
-54
Growth
-33.96%
Revenue / Employee
n/a
Profits / Employee
-$977,238
Market Cap
171.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 105 | -54 | -33.96% |
| Jun 30, 2025 | 110 | -40 | -26.67% |
| Mar 31, 2025 | 109 | -41 | -27.33% |
| Dec 31, 2024 | 157 | 7 | 4.67% |
| Sep 30, 2024 | 159 | -8 | -4.79% |
| Jun 30, 2024 | 150 | -19 | -11.24% |
| Mar 31, 2024 | 150 | -15 | -9.09% |
| Dec 31, 2023 | 150 | -13 | -7.98% |
| Sep 30, 2023 | 167 | 21 | 14.38% |
| Jun 30, 2023 | 169 | 42 | 33.07% |
| Mar 31, 2023 | 165 | 30 | 22.22% |
| Dec 31, 2022 | 163 | 27 | 19.85% |
| Sep 30, 2022 | 146 | 13 | 9.77% |
| Jun 30, 2022 | 127 | 11 | 9.48% |
| Mar 31, 2022 | 135 | 28 | 26.17% |
| Dec 31, 2021 | 136 | 41 | 43.16% |
| Sep 30, 2021 | 133 | 63 | 90.00% |
| Jun 30, 2021 | 116 | 46 | 65.71% |
| Mar 31, 2021 | 107 | 45 | 72.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| ProQR Therapeutics | 166 |
| Zentalis Pharmaceuticals | 166 |
| Prelude Therapeutics | 131 |
| Camp4 Therapeutics | 55 |
| Sol-Gel Technologies | 34 |
| Eledon Pharmaceuticals | 31 |
| Context Therapeutics | 12 |
NKTX News
- 2 months ago - Nkarta to Participate in Evercore Healthcare Conference - GlobeNewsWire
- 2 months ago - Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
- 2 months ago - Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 months ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 3 months ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 5 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 6 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 months ago - Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewsWire